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Ultrastructural events In early calcium oxalate crystal formation
in rats. A model system is described for the induction of renal
calcium oxalate crystals with intraperitoneal injections of sodium
oxalate in rats. Early crystals are formed predominantly in cor-
tical areas. Massive amounts of calcium are associated with this
process, as demonstrated by potassium pyroantimonate staining.
Actual crystal formation appears to be an involved process asso-
ciated with calcium, oxalate, and cellular membranes. Although
overt stone formation was not observed, we feel that the intimate
involvement of membranes during crystal formation may be sim-
ilar to that found in renal stones.
Aspects ultrastructuraux au stade précoce de Ia formation de
cristaux d'oxalate de calcium chez Ic rat. Un modèle d'induction
de cristaux d'oxalate de calcium au moyen d'injections intra-
péritonéales d'oxalate de sodium est décrit chez le rat. Les pre-
miers cristaux sont formés dans les regions corticales. Des quan-
tités importantes de calcium sont impliquées dans ce processus
comme Ic montre Ia coloration par le pyroantimonate de potas-
sium. La formation de cristaux parait un processus complexe
impliquant le calcium, l'oxalate et les membranes cellulaires.
Bien qu'iI n'ait pas été observe de formation de calcul il paraIt
possible que l'implication des membranes au cours de la forma-
tion de cristaux existe aussi pour les calculs rénaux.
The formation of urinary tract calculi in man has
been a noted health problem since the beginning of
recorded history. The systematic collection of data
during the last century suggests that less developed
societies have a preponderance of uric acid, urate
bladder stones, whereas the more industrialized
areas of Western Europe and North America mani-
fest stone disease in the form of renal stones that
are primarily composed of calcium oxalate [1, 2].
Diet and water quality have been implicated as
causative agents in stone disease by certain workers
[3, 4], and others suggest that endogenous sources
of oxalate are as important as exogenous [5, 6]
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sources, but as yet the basic mechanisms in calcu-
logenesis have not been clarified.
Since calcium oxalate stone formation presum-
ably is the result of a series of events beginning with
the formation of calcium oxalate nuclei, numerous
studies have dealt with the physicochemical param-
eters involved in the formation of calcium oxalate
crystals [7—il]. In studies with synthetic urine, Do-
remus, Teich, and Silvis [12] suggested that the nu-
cleation of slightly soluble salts dissolved in aque-
ous solutions takes place so rapidly that in less than
I mm almost all crystal nuclei are formed. Studies
by Prien [13] with fresh urine revealed that calcium
oxalate precipitated in the form of small (5 ) crys-
tals in normal urine but was found also in large crys-
talline aggregates in the urine of stone-formers.
Gardner and Doremus [14] concluded that inhib-
itors in normal urine reduce the growth rate of cal-
cium oxalate dihydrate and also decrease the aggre-
gation of the di- and mono-hydrates. They suggest
that normal urine permits only the formation of
smaller crystals and aggregates of crystals which
are easily passed from the system. Finlayson and
Reid [15] offer evidence that calcium oxalate crys-
tals formed in kidneys are too small to remain
trapped long enough in tubules to serve as a nidus
for stone formation. They further suggest that stone
formation can begin only on particles that are some-
how attached in the renal system.
Early work in Boyce's laboratory [16] revealed
higher levels of a mucoprotein substance in the
urine of stone-formers than it did in normal urine,
and histochemical analyses of calcium oxalate
stones [17] demonstrated that PAS- and colloidal
iron-positive material, presumed to be matrix mate-
rial, formed 2 to 4% of renal calculi as described by
Boyce [18] and is consistently associated with renal
stones. Spherical calcium bodies measuring 5 to 15
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Table 1. Sodium oxalate injection schedule and fixation regimena
15 mm
before
fixation
30 mm
before
fixation
60 mm
before
fixation
6 hr
before
fixation
12 hr
before
fixation
24 hr
before
fixation
no. of rats
Sodium oxalate treatedb
3mg 3 5 6 4 4 2
4mg — — 4 2 4 2
5mg 4 3 7 4 4 2
7mg — — 4 2 4 4
9mg 4 5 12 4 4 2
Saline controls — 1 4 — — —
Ischemic controls — 6
a There were 116 rats in the study.
b The sodium oxalate dose was given per 100 g body wt.
p. in diameter, which are found in the urine of stone-
formers, also have mucopolysaccharides associated
with them [19]. Recent ultrastructural investiga-
tions have revealed membranous, fibrillar. and ve-
sicular material associated with calculi [20, 21], and
also with calcium oxalate crystals formed in renal
tubules [22].
We have undertaken an ultrastructural examina-
tion of the early events leading to the formation of
calcium oxalate crystals. The rat was chosen for our
experimental model because of the ease with which
sodium oxalate injections induce the formation of
calcium oxalate renal crystals [23, 24], and the be-
lief that an understanding of the process of crystal
formation will help provide clues to the processes
involved in the formation of kidney stones typical of
calculous disease.
Cytochemical techniques for the identification of
calcium [25] along with x-ray analysis of the stain
product and crystals in the kidney tubules have al-
lowed us to pinpoint more accurately the earlier
stages of calcium oxalate crystal formation. PAS-
positive membranes, vesicles, and fibnllar material
which we have found associated with calcium oxa-
late crystals in our experimental model are similar
to those thought to be a part of the matrix found in
urinary calculi [17, 21, 26].
Methods
Male Sprague-Dawley rats (each weighing 150 to
300 g) were acclimatized in our animal quarters for
at least 10 days prior to use. They were injected in-
traperitoneally with 3, 4, 5, 7, and 9 mg of sodium
oxalate per 100 g body weight in a 0.22 M solution
of sodium oxalate in 0.9% saline. Control animals
were injected with similar quantities of saline solu-
tion without added sodium oxalate. At various
times following the sodium oxalate injections, the
animals were anesthetized with pentobarbital, 0.1
mg/100 g of body weight, i.p. (50 mg'ml solution).
The details of the fixation schedule are given in
Table 1. Kidneys from all animals were examined
by light microscopy. Electron microscopic and
cytochemical studies were done on saline controls
and experimental animals 15, 30, and 60 mm after
sodium oxalate injections.
Light microscopy. The kidneys were removed
and a transverse central section from each was
placed in alcoholic formalin. Alternatively, a similar
section was removed from kidneys perfused with
fixative prior to preparation for electron micros-
copy as described below. Paraffin sections of the
fixed kidneys were stained with hematoxylin and
eosin. Sections were examined with bright field or
polarizing optics on a Leitz Dialux-20 microscope.
Electron microscopy. Kidneys to be examined ul-
trastructurally were fixed by retrograde perfusion
via the aorta [27] or immersion-fixed with the for-
maldehyde-glutaraldehyde fixative of McDowell
and Trump [28]. For routine electron microscopy,
the tissue was washed several times in a 0.1 M ca-
codylate buffer (pH, 7.2), postfixed in 2% (weight
per volume) osmium tetroxide in the same buffer,
dehydrated in a graded ethanol series, put through
several changes of 100% acetone, and embedded in
Spurr's plastic [29]. Thick sections (0.5 p.) were
stained with toluidine blue for examination with the
light microscope. Ultrathin sections of the embed-
ded tissue were examined unstained in the electron
microscope or poststained with 2% (weight per vol-
ume) methanolic uranyl acetate, followed by Rey-
nolds' lead citrate [30].
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Digestions of calcium oxalate crystals. Thick
sections of plastic-embedded tissue were dried onto
clean glass slides and observed with the polarized
light microscope as either 0.1 N hydrochloric acid or
0.1 M EDTA (pH, 4.3) was added dropwise and left
for 15 to 60 mm under continuous examination.
During this period, the majority of birefringent crys-
talline material disappeared. These sections were
then reembedded in fresh plastic, sectioned, and the
fields containing birefringent material which had
disappeared under the light microscope were exam-
ined with the electron microscope. Tissue samples
also were taken from the primary fixative, rinsed
several times in buffer, and treated with 0.1 N hy-
drochloric acid for 1 hour, postfixed, dehydrated,
and embedded in the standard manner for electron
microscopic examination.
Cytochemistry. Calcium was localized in the tis-
sue at the ultrastructural level by adding 4% (weight
per volume) potassium pyroantimonate (aqueous)
to an equal volume of aqueous 4% (weight per vol-
ume) osmium tetroxide, adjusting the pH to 7.6 with
0.1 N potassium hydroxide and then adding the tis-
sue. The tissue was rinsed three times (10 mm each)
in distilled water to remove the osmium contained
in the primary fixative prior to immersion in the os-
mium and pyroantimonate mixture. As a control,
selected samples of tissue were treated with 10 mM
EGTA at pH 9.4 for 4 hours between the primary
fixative and the osmium and pyroantimonate post-
fixation solution to remove calcium from the tissue.
in a separate experiment, performed to eliminate
nonspecific cellular necrosis as a possible factor in
positive pyroantimonate staining, we subjected six
animals to renal pedicle occlusion for 45 mm fol-
lowed by 15 mm of reflow. Kidneys from these ani-
mals were prepared for electron microscopy and
cytochemical studies as well.
X-ray analysis. Unstained ultrathin sections of
tissue prepared as cited above were examined with
an ORTEC 6230 x-ray analyzer attached to a Phil-
lips 301 electron microscope. Sections (1000 A) of
human calcium oxalate calculi embedded in Spun's
plastic were examined by the same technique for
comparison.
Results
Gross effects of sodium oxalate injections on
rats. The visible effect of low doses (3 mg/100 g
body weight) on the injected rats was minimal. As
the quantity of injected sodium oxalate increased,
the rats developed motor difficulties. At the highest
level used (9 mgIlOO g body weight), the rats exhib-
ited partial dysfunction of hindquarter muscle
groups and became lethargic for 5 or 6 hours in most
cases. Their urinary output dropped, compared to
that of controls, over 8 hours of observation. When
surgery was performed, it was noted that small ves-
sel breaks resulted in greater bleeding than was nor-
mal. The peritoneal cavity of experimental animals
had considerable edema. The aorta appeared par-
tially constricted, which made cannulation some-
what more difficult than it was in control animals.
Light microscopy. Examination of paraflin sec-
tions of perfused and immersion-fixed kidneys re-
vealed that animals treated with the smallest
amount of sodium oxalate (3 mg/100 g body weight)
for the shortest period of time (15 mm) had crystals
in the three major areas of the kidney (cortex, me-
dulla, papilla). The crystals were birefringent, and
many were in the rosette or sheaf pattern character-
istic of calcium oxalate. In perfused kidneys, the
crystals were always within the tubular lumens
(Fig. 1), appeared to be free in the intraluminal
space, but occasionally were directly apposed to
the brush border of proximal convoluted tubules.
Frequently cellular debris was found associated
with the crystals at all dosages. Higher concentra-
tions of sodium oxalate resulted in progressively
greater numbers of crystals in the kidneys, mainly
cortical in distribution, larger crystals, and more
cellular damage within the tubules. The maximum
crystal distribution was reached at the 9 mg!lOO g
dose level to which the animal was exposed for I
hour. In immersion-fixed kidneys, animals with 3
mg!100 g doses of sodium oxalate typically had col-
lapsed tubules in the cortical and medullary regions
at 12 hours after injection (Fig. 2), whereas those
which received a 9 mgIlOO g dose had tubules with
more patent lumens containing amorphous cellular
debris (Fig. 3). Animals examined at 1, 6, 12, and 24
hours showed a variable response. Those that re-
ceived either 3 or 4 mgIlOO g had crystals through-
out the kidney after 1 hour (in low numbers) and
after 6 hours had virtually cleared the kidneys of
crystals. Animals receiving single injections of 5, 7,
and 9 mg/100 had massive crystal deposition within
the kidney at 1 hour, but chiefly cortical in distribu-
tion. As the dose increased, the number of crystals
cleared from the tissue at 6, 12, and 24 hours after
injection decreased. The cortex cleared first, fol-
lowed by the medulla and papilla. At the highest
dose, the kidneys still had extensive deposits of
crystals in the cortex, medulla, and papilla after 24
hours.
Electron microscopy. Conventional fixation of
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Fig. 1. Light micrograph of cortical region of kidney from animal treated with sodium oxalate (NaOx) and then perfused with fixative,
showing birefrmn gent crystals (arrows) free in tubular lumens. H & E section was viewed with partially polarized light (x225).
Fig. 2. Light micrograph of cortical region of kidney from rat injected with 3 mg/100 g sodium oxalate, and immerse-fixed 12 hours later.
This H & E preparation was viewed with partially polarized light (x225).
Fig. 3. Light micrograph of cortical region of kidney from rat injected with 9 mgIIOO g sodium oxalate and immerse-fixed 12 hours later.
Note birefringent crystals within tubular lumens (arrows). This H & E preparation was viewed with partially polarized light (x225).
Fig. 4. Electron micrograph of proximal tubule lumen from rat treated with 9 mg/100 g sodium oxalate. Numerous holes (H) are left
where crystals were pulled from the plastic and are surrounded by membranes (M) and pieces of microvillous-like (MVL) material
(x 13,500).
treated kidneys revealed two problems. The first
was that the numbers of crystals in ultrathin sec-
tions of kidney tissue subjected to lesser levels of
sodium oxalate were too few for systematic exami-
nation. Consequently, most observations are re-
lated to higher-dose animals, although crystal struc-
ture was identical at all doses used. The second
problem concerned the difficulty of sectioning crys-
tals of calcium oxalate, which were essentially unin-
filtrated with plastic. The crystalline material was
consistently pulled from the sections by the knife
edge, resulting in distortion of the plastic and near-
by tissue. It was still possible to see that mem-
branes were associated with the crystals in luminal
i. 
r 
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Fig. 5. Electron micrograph of cortical tubule lumen with hole (arrow) left by crystal which was pulled from plastic during sectioning.
Note numerous membranes (M) associated with hole. Animals were treated with 9 mg/100 g sodium oxalate before fixation (x35,200).
Fig. 6. Electron micrograph of proximal tubule with crystal in lumen (Cr) stained with pyroantimonate. Stain product is also in between
microvilli and in apical vesicles (x 14,200).
Fig. 7. Electron micrograph of crystal in tubule lumen stained with pyroantimonate. Note whorls and pieces of membranes (M) associat-
ed with crystal (xlO,950).
Fig. 8. Electron micrograph of proximal tubule of rat perfused 1 hour after receiving 5 mg/lOO g sodium oxalate. Tissue was stained with
pyroantimonate. Membranes (M) associated with microvilli and in apical vacuole are shown (x 14,150).
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spaces, but the actual physical relationship of the
membranes to the crystals was partially obscured
(Fig. 4 and 5). Similar difficulties have been illus-
trated by others [22].
For routine electron microscopy, digestion with
hydrochloric acid or EDTA was done. This treat-
ment eliminated the tearing problem associated
with intact crystals and did not appear to affect the
disposition of the membranous and fibrillar material
associated with the crystals. An unexpected divi-
dend of pyroantimonate staining, however, was that
crystalline material that stained also sectioned eas-
ily, and the pulling and tearing artifacts associated
with the untreated crystal was fortuitously eliminat-
ed (Fig. 6). Vesicular, membranous, and fibrillar
material was always associated with crystals (Figs.
4 to 7). Membranes were frequently present within
the tubular lumens prior to the actual appearance of
crystals (Fig. 8).
Cytochemical localization of calcium in cortical
tissue by the use of potassium pyroantimonate dem-
onstrated the presence of presumed calcium at all
sodium oxalate dose levels (Table 2). Increasing the
amount of injected sodium oxalate and the length of
exposure was associated with an increase in the
quantity of stain product found. With high doses of
sodium oxalate (9 mg/100 g), in animals perfused 60
mm after injection, stain product appeared in the
proximal tubular lumens (Figs. 9 and 10), apical
vesicles, vacuole system of the proximal tubules,
and among the microvilli of the brush border [6, 9,
10]. It was also heavily deposited on crystals (Figs.
6 and 7), associated with membranous sacs within
the apical vesicle and vacuole system, and the tubu-
lar lumen (Fig. 8). Stain also was found sometimes
in interstitial spaces near the peritubular capillary
system, and occasionally in the urinary space of the
glomerulus (Fig. 11). Flocculent material in some
tubular lumens stained with pyroantimonate though
the majority of such materials did not (Figs. 9, 10).
Lower concentrations of sodium oxalate to which
the animals were exposed for a shorter time result-
ed in sporadic staining with the pyroantimonate
method. Some tubules showed no staining at all,
whereas others had reduced amounts of stain prod-
uct in all the same locations as in animals treated
with heavier doses. After 60 mm at all dose levels,
stain product was associated with cell types and cel-
lular components listed above.
Pyroantimonate treatment of kidneys from ani-
mals subjected to 9 mg/100 g for 60 mm, perfused,
and then soaked in EGTA for 4 hours revealed no
staining in any part of the proximal tubules (Fig. 12)
or other parts of the nephron. Occasional calcium
oxalate crystals in tubular lumens that had not had
all their calcium component removed by the EGTA
still stained to some extent. Kidneys from normal
animals, and saline and ischemic controls, which
were perfused with fixative, showed no staining af-
ter pyroantimonate treatment (Fig. 13).
Energy dispersive (x-ray) analysis. Ultrathin sec-
tions of rat kidney cortex containing crystals were
examined to determine if the crystals contained cal-
cium. These studies demonstrated that the major
component of the crystals was calcium, with no dis-
cernible magnesium. Readings taken of the particu-
late stain product in the apical vesicle and vacuole
system of proximal tubules in crystal-bearing tissue
were questionable due to the low counts per minute
generated by the sparse stain product, but a slight
shoulder was indicated in the region of calcium. Nu-
clei and cytoplasm of the proximal tubular cells well
below the apical vesicle and vacuole system in ani-
mals subjected to 9 mgIlOO g doses for 1 hour were
scanned for the presence of calcium with the micro-
probe and revealed none.
Discussion
These experiments were done to investigate the
early structural events occurring in the formation of
calcium oxalate crystals in the kidney tubule. The
advantage of the intraperitoneal method described
Table 2. Deposition of stain product in proximal tubules of perfused kidneysa
Perfused 15 mm Perfused 30 mm
after injection after injection
Perfused 60 mm
after injection
Sodium oxalate
3mg
5mg
9mg
Saline controls
Ischemic controls
+ ++
+ ++
+ +++
(No staining product found anywhere in tissue)
(No staining product found anywhere in tissue)
++
++
++++
a One plus (+) is the least amount of staining; four plus (+ + + +) is the most amount of staining.
b The sodium oxalate dose was given per 100 g body wt.
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Fig. 9. Electron ,njcrograph of proximal tubule of rat fixed 1 hour after receiving 9 mg/100 g sodium oxalate. The tissue is stained with
pyroantimonate to reveal product in the apical vesicle and vacuole system, among microvilli, and in the tubular lumen (arrows) (<7920).
here, as compared to previous models, is the rapidi-
ty and constancy with which crystal formation can
be induced. Although the quantities of sodium oxa-
late administered to the rats in our studies clearly
provides an oxalate challenge greater than that en-
countered in human stone disease, we feel that the
obtained results still provide us with important in-
formation about early formation of crystals that
might be extrapolated to clinical conditions. The
potassium pyroantimonate procedure provided an
excellent ultrastructural detail of the crystals and
did not affect ultrastructural analysis of cells. The
method is for calcium ions, however, and we have
no direct method for demonstrating the participa-
tion of oxalate ions in the formation of the crystals.
Inferentially, the crystals are calcium oxalate, be-
cause they have the characteristic birefringent pat-
tern associated with calcium oxalate.
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FIg. 10. Electron micrograph of proximal tubule of rat receiving 9 mg/IOU g sodium oxalate 1 hour prior to perfusion. Note flocculent
material located within the lumen, some of which is stained with pyroantimonate (x6580).
Fig. 11. Electron micrograph of glomerulus from cortex of rat which was fixed 1 hour after receiving 5 mg/100 g sodium oxalate. The
tissue was treated with pyroantimonate. Stain product is located in urinary (Bowman's) space around podocytes (X7425).
Fig. 12. Electron micrograph of proximal tubule of rat given 9 mg/lOU g sodium oxalate, perfused I hour later, treated with EGTA and
then pyroantimonate. No stain appears in tissue (x31,700).
Fig. 13. Electron micrograph of proximal tubule of normal perfused rat stained with pyroantimonate. No staining occurred (x7450).
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A number of groups have used potassium pyroan-
timonate for the cytochemical demonstration of cal-
cium and sodium in tissues [25, 31—35]. Each study
describes variations concerning tissue examined,
pH used, and point at which pyroantimonate is in-
troduced to the tissue. Lewis and Knight [36] give a
detailed discussion of the pitfalls of this technique.
Pyroantimonate will complex with sodium, potas-
sium, magnesium, and calcium ions. If used in the
initial aldehyde fixative, soluble calcium, sodium,
and magnesium ions in the tissue will be precipi-
tated as well as those insoluble compounds, such as
calcium oxalate, which can react with pyroantimo-
nate. To prevent this less specific reaction, we left
our experimental tissues in aldehyde solutions for
several hours to several weeks and then washed in
three changes of distilled water prior to cyto-
chemical staining. This apparently removed the sol-
uble ions, so that the material that did stain was pre-
sumed to be calcium for the following reasons: (1)
Animals which had not received injections of so-
dium oxalate prior to pyroantimonate staining ex-
hibited no reaction product anywhere. (2) Animals
treated with EGTA to remove calcium prior to py-
roantimonate staining had little or no stain product
anywhere except on the large, multicrystalline ag-
gregations in tubular lumens (this treatment elimi-
nates the possibility that staining in oxalate-treated
animals could be due to sodium or potassium be-
cause EGTA does not chelate them). (3) When we
examined with the x-ray microprobe crystals in
tubular lumens that reacted with the pyroantimo-
nate stain, we found calcium in large amounts, but
no magnesium. The stain product associated with
the crystals was identical in structure to that found
in areas of the kidney with particulate material but
devoid of polycrystalline aggregates. In addition,
areas of tissue with no stain product scanned with
the microprobe were found to be calcium-free.
The initial location of crystals formed within kid-
ney tubules has been a matter of some discussion.
Jordan, Finlayson, and Luxemberg [23] reported
that rats injected with sodium oxalate formed cal-
cium oxalate polycrystalline particles from 5 to 20 p
in diameter throughout the medulla and renal cortex
in intratubular spaces. Vermeulen [11] and Malek
and Boyce [37] found that the renal cortex was al-
ways less involved than was the medulla, which
typically was more heavily studded with micro-
calculi nearer the papillary tip. This represents one
of the most notable differences between our one-
injection acute model and the more traditional
chronic administration of lithogen models because
the cortex is heavily involved in the early post-
injection periods. Wright and Hodgkinson [38]
found in rats that calcium oxalate crystals were at-
tached to the basement membrane of tubule cells,
though most crystals were located in tubule lumen.
In the model described here, all crystals were pres-
ent in the tubular lumen in early stages, whether in
cortex or medulla, and none were located in the in-
terstitium.
Cornelius and Moulton [17] proposed that calcu-
bus mucoid material may have originated as a se-
cretory product of renal tubular cells. Resnick and
Boyce believe that matrix substance A is probably
of renal origin. It is detectable immunologically in
renal tissue with calculi as well as it is in renal tissue
containing only crystals [19]. They suggest that an
early step in the formation of stones may be the
binding of calcium by proteinaceous materials, in
our studies, cellular membranous material is in-
variably found within the tubules of oxalate-treated
animals, and it always formed a part of the crystal.
This membranous material may be a source of some
of the substances found in urine and associated with
stones. Some of it may come from senescent cells of
the tubular epithelium, and some may come from
the sboughing of cell surface components of tubular
cells because pieces of aberrant microvillus-like
material are consistently found near crystalline ma-
terial. Some may also be derived from intracellular
membranes (Fig. 8). Similar findings have been de-
scribed in mice fed a chronic lithogenic diet [22].
Our results demonstrate that earliest formation of
calcium oxalate crystals within the intratubular lu-
men is a complex event. In contrast to calcium oxa-
late crystal formation in vitro, the formation of such
crystals in the kidney involves, at the least, an un-
defined interaction between calcium, oxalate, cellu-
lar membranes, and other components. Construc-
tion of a crystal in this experimental model involves
massive mobilization of calcium, presumably re-
lated to oxalate excretion. These complex with cel-
lular membranes derived from tubular cells to form
an organized crystalline array. Whether individual
cells are killed in this process is not clear. Equally
unclear is the origin of the cellular membranes in-
volved in the organization of the crystal. Our data
suggest that calcium is complexed with the micro-
villous membranes, possibly with the anionic por-
tions of the cell coat, but the role played by the lu-
minal vacuolar system and other cytoplasmic mem-
branes is less certain.
Our hypothesis is that early formation of crystals
is a phenomenon which involves only cellular lumi-
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nal membranes. Although formation of such crys-
tals may cause cellular damage or death, such
events are secondary and not necessarily related to
crystal formation. Further work is underway to test
this concept.
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